In this episode of Lipid Insights, we explore the NLA’s recent expert meta-analysis, “Low-density lipoprotein cholesterol lowering and risk of major adverse cardiovascular events in primary prevention trials.”
Lead author Dinesh K. Kalra, MD, MBA, FNLA and key author Kevin C. Maki, PhD, CLS, MNLA join host Alan S. Brown, MD, FACC, MNLA to examine the relationship between LDL-C reduction and major adverse cardiovascular events in primary prevention trials. Together, they break down the findings, clinical implications, and why early LDL-C lowering remains central to preventing first cardiovascular events.
Read the meta-analysis HERE.
